Clinicobiological characteristics and treatment efficacy of novel agents in chronic lymphocytic leukemia with IGLV3-21 R110

Autor: Paul J. Hengeveld, Y. Emre Ertem, Julie M. N. Dubois, Clemens H. M. Mellink, Anne-Marie van der Kevie-Kersemaekers, Ludo M. Evers, Kim Heezen, P. Martijn Kolijn, Olaf R. F. Mook, M. Mahdi Motazacker, Kazem Nasserinejad, S. Kersting, Peter E. Westerweel, Carsten U. Niemann, Arnon P. Kater, Anton W. Langerak, Mark-David Levin
Přispěvatelé: Immunology, Hematology, Human Genetics, ARD - Amsterdam Reproduction and Development, ACS - Pulmonary hypertension & thrombosis, ANS - Complex Trait Genetics, CCA - Cancer biology and immunology, Experimental Immunology, Clinical Haematology, CCA - Cancer Treatment and Quality of Life
Jazyk: angličtina
Rok vydání: 2022
Předmět:
Zdroj: Leukemia, 36(7), 1935-1938. Nature Publishing Group
Hengeveld, P J, Ertem, Y E, Dubois, J M N, Mellink, C H M, van der Kevie-Kersemaekers, A-M, Evers, L M, Heezen, K, Kolijn, P M, Mook, O R F, Motazacker, M M, Nasserinejad, K, Kersting, S, Westerweel, P E, Niemann, C U, Kater, A P, Langerak, A W & Levin, M-D 2022, ' Clinicobiological characteristics and treatment efficacy of novel agents in chronic lymphocytic leukemia with IGLV3-21R110 ', Leukemia, vol. 36, no. 7, pp. 1935-1938 . https://doi.org/10.1038/s41375-022-01600-6
ISSN: 0887-6924
DOI: 10.1038/s41375-022-01600-6
Databáze: OpenAIRE
Externí odkaz: